As a strategic
goal, liaison with other European and International organisations
in the area of pharmaceutical sciences is essential for EUFEPS.
and participates in the scientific programme of the World Congress
in Pharmaceutical Sciences, and is organising the World Conference
on Drug Absorption and Drug Delivery. Other initiatives include
annual Optimising Drug Development conference series, the New
Safe Medicines Faster project aimed at the EU 6th RTD Framework
Programme, educational and training programmes, as well as the
biennial Congresses in the Pharmaceutical Sciences, which bring
together European scientists from all the disciplines comprising
the pharmaceutical sciences.
Formal and informal
relationships with other organisations include:
- American Association
of Pharmaceutical Scientists (AAPS)
- American Society
of Clinical Pharmacology & Therapeutics (ASCPT)
- European Association
of Clinical Pharmacology and Therapeutics (EACPT)
- FIP Board of Pharmaceutical
Sciences (FIP BPS)
- International Society
for the Study of Xenobiotics (ISSX)
- Center for Drug
Development Science (CDDS),
Washington, DC USA
- European Center
of Pharmaceutical Medicine (ECPM),
- European Co-operation
in the Field of Scientific and Technical Research/Medical Research/Modelling
during drug development (COST B15)
- European Federation
of Pharmaceutical Industries and Associations (EFPIA),
Centre for Drug Research (LACDR),
Leiden, The Netherlands
- Tufts Center for
the Study of Drug Development (CSDD),
Boston, MA USA.
The European Medicines
Evaluation Agency (EMEA).
It has recognised EUFEPS as an independent Pan-European scientific
US Food and Drug Administration Center for Drug Evaluation and
Research (FDA CDER).
A good working relationship is in place as an active FDA Liaison
Officer to EUFEPS (Dr Lawrence J. Lesko, PhD) was appointed.
EUFEPS has developed relations with the EU on the level of the
Commission, and EUFEPS has an active Liaison Officer to European
Affairs (Professor Ole J. Bjerrum, Danish University of Pharmaceutical
Science, Copenhagen, Denmark). This gives short access to early
information on further developments of the EU Research Programme,
particularly, but also to other relevant and important Europan
collaboration matters and issues.